AAAAAA

   
Results: 1-25 | 26-33
Results: 1-25/33

Authors: MORISSETTE M GOULET M GRONDIN R BLANCHET P BEDARD PJ DIPAOLO T LEVESQUE D
Citation: M. Morissette et al., ASSOCIATIVE AND LIMBIC REGIONS OF MONKEY STRIATUM EXPRESS HIGH-LEVELSOF DOPAMINE D-3 RECEPTORS - EFFECTS OF MPTP AND DOPAMINE AGONIST REPLACEMENT THERAPIES, European journal of neuroscience, 10(8), 1998, pp. 2565-2573

Authors: DOYON J LAFORCE R BOUCHARD G GAUDREAU D ROY J POIRIER M BEDARD PJ BEDARD F BOUCHARD JP
Citation: J. Doyon et al., ROLE OF THE STRIATUM, CEREBELLUM AND FRONTAL LOBES IN THE AUTOMATIZATION OF A REPEATED VISUOMOTOR SEQUENCE OF MOVEMENTS, Neuropsychologia, 36(7), 1998, pp. 625-641

Authors: CIONI M RICHARDS CL MALOUIN F BEDARD PJ LEMIEUX R
Citation: M. Cioni et al., CHARACTERISTICS OF THE ELECTROMYOGRAPHIC PATTERNS OF LOWER-LIMB MUSCLES DURING GAIT IN PATIENTS WITH PARKINSONS-DISEASE WHEN OFF AND ON L-DOPA TREATMENT, Italian journal of neurological sciences, 18(4), 1997, pp. 195-208

Authors: GOULET M MORISSETTE M CALON F BLANCHET PJ FALARDEAU P BEDARD PJ DIPAOLO T
Citation: M. Goulet et al., CONTINUOUS OR PULSATILE CHRONIC D-2 DOPAMINE-RECEPTOR AGONIST (U91356A) TREATMENT OF DRUG-NAIVE 4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MONKEYSDIFFERENTIALLY REGULATES BRAIN D-1 AND D-2 RECEPTOR EXPRESSION - IN-SITU HYBRIDIZATION HISTOCHEMICAL ANALYSIS, Neuroscience, 79(2), 1997, pp. 497-507

Authors: DOYON J GAUDREAU D LAFORCE R CASTONGUAY M BEDARD PJ BEDARD F BOUCHARD JP
Citation: J. Doyon et al., ROLE OF THE STRIATUM, CEREBELLUM, AND FRONTAL LOBES IN THE LEARNING OF A VISUOMOTOR SEQUENCE, Brain and cognition, 34(2), 1997, pp. 218-245

Authors: MORISSETTE M GOULET M SOGHOMONIAN JJ BLANCHET PJ CALON F BEDARD PJ DIPAOLO T
Citation: M. Morissette et al., PREPROENKEPHALIN MESSENGER-RNA EXPRESSION IN THE CAUDATE-PUTAMEN OF MPTP MONKEYS AFTER CHRONIC TREATMENT WITH THE D-2 AGONIST U91356A IN CONTINUOUS OR INTERMITTENT MODE OF ADMINISTRATION - COMPARISON WITH L-DOPA THERAPY, Molecular brain research, 49(1-2), 1997, pp. 55-62

Authors: GUTTMAN M OTT E TRAGNER H BEDARD PJ POURCHER E CURRAN T GOODRIDGE A GUTTMAN M HOBSON D KING D MARTIN WRW MENDIS T RAJPUT A RIVEST J STOESSL J SUCHOWERSKY O MORAN J MURPHY R WALSH B ONEILL DO KLEMPERER B MARTIN M OEHLWEIN C POLZER U REICHMANN H SCHIMEK J SCHLENKER M SCHWARTZ A MEIER D TRAUBNER P BENETIN J BOMHOF MAM HOVESTADT A VREELING FW WOLTERS ECMJ BRODDIE HG CLARKE C CLOUGH CJ LOIZOU L NEWMAN PK PYE IF
Citation: M. Guttman et al., DOUBLE-BLIND COMPARISON OF PRAMIPEXOLE AND BROMOCRIPTINE TREATMENT WITH PLACEBO IN ADVANCED PARKINSONS-DISEASE, Neurology, 49(4), 1997, pp. 1060-1065

Authors: GRONDIN R BEDARD PJ BRITTON DR SHIOSAKI K
Citation: R. Grondin et al., POTENTIAL THERAPEUTIC USE OF THE SELECTIVE DOPAMINE D-1 RECEPTOR AGONIST, A-86929 - AN ACUTE STUDY IN PARKINSONIAN LEVODOPA-PRIMED MONKEYS, Neurology, 49(2), 1997, pp. 421-426

Authors: DOUCET JP NAKABEPPU Y BEDARD PJ HOPE BT NESTLER EJ JASMIN BJ CHEN JS IADAROLA MJ STJEAN M WIGLE N BLANCHET P GRONDIN R ROBERTSON GS
Citation: Jp. Doucet et al., CHRONIC ALTERATIONS IN DOPAMINERGIC NEUROTRANSMISSION PRODUCE A PERSISTENT ELEVATION OF DELTA-FOSB-LIKE PROTEIN(S) IN BOTH THE RODENT AND PRIMATE STRIATUM, European journal of neuroscience, 8(2), 1996, pp. 365-381

Authors: BLANCHET PJ GRONDIN R BEDARD PJ
Citation: Pj. Blanchet et al., DYSKINESIA AND WEARING-OFF FOLLOWING DOPAMINE D-1 AGONIST TREATMENT IN DRUG-NAIVE ETHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-LESIONED PRIMATES, Movement disorders, 11(1), 1996, pp. 91-94

Authors: BLANCHET PJ ALLARD P GREGOIRE L TARDIF F BEDARD PJ
Citation: Pj. Blanchet et al., RISK-FACTORS FOR PEAK DOSE DYSKINESIA IN 100 LEVODOPA-TREATED PARKINSONIAN-PATIENTS, Canadian journal of neurological sciences, 23(3), 1996, pp. 189-193

Authors: SOGHOMONIAN JJ PEDNEAULT S BLANCHET PJ GOULET M DIPAOLO T BEDARD PJ
Citation: Jj. Soghomonian et al., L-DOPA REGULATES GLUTAMATE DECARBOXYLASES MESSENGER-RNA LEVELS IN MPTP-TREATED MONKEYS, Molecular brain research, 39(1-2), 1996, pp. 237-240

Authors: MORISSETTE M GOULET M CALON F FALARDEAU P BLANCHET PJ BEDARD PJ DIPAOLO T
Citation: M. Morissette et al., CHANGES OF D-1 AND D-2 DOPAMINE-RECEPTOR MESSENGER-RNA IN THE BRAINS OF MONKEYS LESIONED WITH 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE - CORRECTION WITH CHRONIC ADMINISTRATION OF L-3,4-DIHYDROXYPHENYLALANINE, Molecular pharmacology, 50(5), 1996, pp. 1073-1079

Authors: BLANCHET PJ GRONDIN R BEDARD PJ SHIOSAKI K BRITTON DR
Citation: Pj. Blanchet et al., DOPAMINE D-1 RECEPTOR DESENSITIZATION PROFILE IN MPTP-LESIONED PRIMATES, European journal of pharmacology, 309(1), 1996, pp. 13-20

Authors: GRONDIN R GOULET M DIPAOLO T BEDARD PJ
Citation: R. Grondin et al., CABERGOLINE, A LONG-ACTING DOPAMINE D-2-LIKE RECEPTOR AGONIST, PRODUCES A SUSTAINED ANTIPARKINSONIAN EFFECT WITH TRANSIENT DYSKINESIAS IN PARKINSONIAN DRUG-NAIVE PRIMATES, Brain research, 735(2), 1996, pp. 298-306

Authors: BLANCHET PJ GOMEZMANCILLA B DIPAOLO T BEDARD PJ
Citation: Pj. Blanchet et al., IS STRIATAL DOPAMINERGIC RECEPTOR IMBALANCE RESPONSIBLE FOR LEVODOPA-INDUCED DYSKINESIA, Fundamental and clinical pharmacology, 9(5), 1995, pp. 434-442

Authors: BEDARD PJ GOMEZMANCILLA B BLANCHET P GRONDIN R DIPAOLO T
Citation: Pj. Bedard et al., DOPAMINE-RECEPTOR FAMILIES AND THE TREATMENT OF PARKINSONS-DISEASE, Clinical neuropharmacology, 18, 1995, pp. 178-187

Authors: ROY E COTE PY GREGOIRE L PARENT A BEDARD PJ
Citation: E. Roy et al., MESENCEPHALIC GRAFTS PARTIALLY RESTORE NORMAL NIGRAL DYNORPHIN LEVELSIN 6-HYDROXYDOPAMINE-LESIONED RATS TREATED CHRONICALLY WITH L-DIHYDROXYPHENYLALANINE, Neuroscience, 66(2), 1995, pp. 413-425

Authors: BLANCHET PJ GOMEZMANCILLA B BEDARD PJ
Citation: Pj. Blanchet et al., DOPA-INDUCED PEAK DOSE DYSKINESIA - CLUES IMPLICATING D2 RECEPTOR-MEDIATED MECHANISMS USING DOPAMINERGIC AGONISTS IN MPTP MONKEYS, Journal of neural transmission. Supplementum, (45), 1995, pp. 103-112

Authors: BEDARD PJ
Citation: Pj. Bedard, D-1 RECEPTORS IN NEUROLOGY AND PSYCHIATRY - AN OVERVIEW, Progress in neuro-psychopharmacology & biological psychiatry, 19(5), 1995, pp. 713-726

Authors: GAGNON C GOMEZMANCILLA B MARKSTEIN R BEDARD PJ DIPAOLO T
Citation: C. Gagnon et al., EFFECT OF ADDING THE D-1 AGONIST CY-208-243 TO CHRONIC BROMOCRIPTINE TREATMENT OF MPTP-MONKEYS - REGIONAL CHANGES OF BRAIN DOPAMINE-RECEPTORS, Progress in neuro-psychopharmacology & biological psychiatry, 19(4), 1995, pp. 667-676

Authors: PETITCLERC M BEDARD PJ DIPAOLO T
Citation: M. Petitclerc et al., PROGESTERONE RELEASES DOPAMINE IN MACE AND FEMALE RAT STRIATUM - A BEHAVIORAL AND MICRODIALYSIS STUDY, Progress in neuro-psychopharmacology & biological psychiatry, 19(3), 1995, pp. 491-497

Authors: BLANCHET PJ CALON F MARTEL JC BEDARD PJ DIPAOLO T WALTERS RR PIERCEY MF
Citation: Pj. Blanchet et al., CONTINUOUS ADMINISTRATION DECREASES AND PULSATILE ADMINISTRATION INCREASES BEHAVIORAL SENSITIVITY TO A NOVEL DOPAMINE D-2 AGONIST (U-91356A) IN MPTP-EXPOSED MONKEYS, The Journal of pharmacology and experimental therapeutics, 272(2), 1995, pp. 854-859

Authors: STPIERRE JA BEDARD PJ
Citation: Ja. Stpierre et Pj. Bedard, SYSTEMIC ADMINISTRATION OF THE NMDA RECEPTOR ANTAGONIST MK-801 POTENTIATES CIRCLING INDUCED BY INTRASTRIATAL MICROINJECTION OF DOPAMINE, European journal of pharmacology, 272(2-3), 1995, pp. 123-129

Authors: CALON F GOULET M BLANCHET PJ MARTEL JC PIERCEY MF BEDARD PJ DIPAOLO T
Citation: F. Calon et al., LEVODOPA OR D2 AGONIST-INDUCED DYSKINESIA IN MPTP MONKEYS - CORRELATION WITH CHANGES IN DOPAMINE AND GABA(A) RECEPTORS IN THE STRIATOPALLIDAL COMPLEX, Brain research, 680(1-2), 1995, pp. 43-52
Risultati: 1-25 | 26-33